Drug-Driven Synthetic Lethality: Bypassing Tumor Cell Genetics with a Combination of AsiDNA and PARP InhibitorsWael Jdey, Marie Dutreix, Sylvain Thierry et al.|Clinical Cancer Research|2016Cited by 42
Differential alternative RNA splicing and transcription events between tumors from African American and White patients in The Cancer Genome AtlasMuthana Al Abo, Jennifer A. Freedman, Terry Hyslop et al.|Genomics|2021Cited by 14
RNA splicing and aggregate gene expression differences in lung squamous cell carcinoma between patients of West African and European ancestryApril Deveaux, Jennifer A. Freedman, Tyler A. Allen et al.|Lung Cancer|2021Cited by 10
Supplementary figure S1 from Drug-Driven Synthetic Lethality: Bypassing Tumor Cell Genetics with a Combination of AsiDNA and PARP InhibitorsWael Jdey, Marie Dutreix, Sylvain Thierry et al.|Unknown|2023Cited by 0
Supplementary figure S3 from Drug-Driven Synthetic Lethality: Bypassing Tumor Cell Genetics with a Combination of AsiDNA and PARP InhibitorsWael Jdey, Marie Dutreix, Sylvain Thierry et al.|Unknown|2023Cited by 0